Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2681891 | 0.87 | ABCB1 (0.43) | ABCB1CYP3A4 | |
| SCHEMBL19946436 | 0.87 | ABCB1 (0.43) | ABCB1CYP3A4 | |
| SCHEMBL27818653 | 0.87 | ABCB1 (0.43) | ABCB1CYP3A4 | |
| SCHEMBL2682545 | 0.87 | ABCB1 (0.43) | ABCB1CYP3A4 | |
| SCHEMBL29684635 | 0.86 | ABCB1 (0.64) | ABCB1 | |
| SCHEMBL667137 | 0.86 | ABCB1 (0.64) | ABCB1 | |
| SCHEMBL2681881 | 0.86 | ABCB1 (0.64) | ABCB1 | |
| SCHEMBL2682557 | 0.86 | ABCB1 (0.64) | ABCB1 | |
| SCHEMBL2682455 | 0.84 | ABCB1 (0.53) | ABCB1 | |
| SCHEMBL2780543 | 0.84 | ABCB1 (0.53) | ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9598355-B2 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2017-03-21 | — | — | US | disclosed |
| US-20150099636-A1 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | INTREXON CORP (US) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099636-A1 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | NR2E3, CRYZ, TCF12 | ABCB1 692/4885CYP3A4 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.